MG
CFMS

Michael Gelband’s Conformis, Inc. Common Stock CFMS Stock Holding History

Michael Gelband’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,386
Closed -$30K – 2477
2022
Q2 		$30K Sell
3,386
-2,187
-39% -$25K ﹤0.01% 1835
2022
Q1 		$87K Sell
5,573
-57
-1% -$937 ﹤0.01% 2016
2021
Q4 		$107K Buy
5,630
+1,856
+49% +$47.6K ﹤0.01% 1946
2021
Q3 		$125K Buy
3,774
+2,184
+137% +$77K ﹤0.01% 1881
2021
Q2 		$46K Buy
1,590
+167
+12% +$3.94K ﹤0.01% 2226
2021
Q1 		$35K Buy
+1,423
New +$38.4K ﹤0.01% 2047

Other funds holding CFMS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return

Michael Gelband's CFMS Position: Q3 2022 in Review

Michael Gelband sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2022, closing a stake of 3,386 shares — an estimated $30K sold.

Michael Gelband first reported a position in CFMS in Q1 2021 and held it in 6 quarters. The position peaked at $125K in Q3 2021. 69 funds tracked by Wall St. Rank hold CFMS as of Q3 2022.

  • Michael Gelband reported no remaining Conformis, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Michael Gelband sold 3,386 Conformis, Inc. Common Stock shares in Q3 2022, an estimated $30K.
  • Michael Gelband first reported a position in Conformis, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Michael Gelband's Conformis, Inc. Common Stock position peaked at $125K in Q3 2021.
  • 69 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.